Luminza, Ricardo G.

HRN: 28-93-66  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2026
CEFTRIAXONE 1G (VIAL)
05/03/2026
05/10/2026
IV
1g
Q12
Multiple Abrasion, Intertrochanteric Fracture Right
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: